CADUET

This brand name is authorized in Austria, Australia, Canada, Spain, France, Hong Kong, Croatia, Japan, Lithuania, Malta, Mexico, Nigeria, Romania, Singapore, Tunisia, Turkey, United States, South Africa

Active ingredients

The drug CADUET contains a combination of these active pharmaceutical ingredients (APIs):

1 Amlodipine UNII 864V2Q084H - AMLODIPINE BESYLATE

Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle. Read about Amlodipine

2 Atorvastatin UNII 48A5M73Z4Q - ATORVASTATIN CALCIUM TRIHYDRATE

Atorvastatin is a selective, competitive inhibitor of HMG-CoA reductase. Atorvastatin lowers plasma cholesterol and lipoprotein serum concentrations by inhibiting HMG-CoA reductase and subsequently cholesterol biosynthesis in the liver and increases the number of hepatic LDL receptors on the cell surface for enhanced uptake and catabolism of LDL. Read about Atorvastatin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CADUET Film-coated tablet	Marketing Authorisation Holder	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C10BX03	Atorvastatin and amlodipine	C Cardiovascular system → C10 Lipid modifying agents → C10B Lipid modifying agents, combinations → C10BX Lipid modifying agents in combination with other drugs
Discover more medicines within C10BX03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 9051J, 9052K, 9053L, 9054M, 9055N, 9056P
Country: CA	Health Products and Food Branch	Identifier(s): 02273233, 02273241, 02273268, 02273276, 02273284, 02273292, 02273306, 02273314
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 67325, 67326
Country: FR	Base de données publique des médicaments	Identifier(s): 60386460, 60772273, 63123849, 65364681, 66709963
Country: HK	Department of Health Drug Office	Identifier(s): 53714, 53715, 53716, 53717, 53718, 53719, 53720, 53721
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-444337926, HR-H-732959683
Country: JP	医薬品医療機器総合機構	Identifier(s): 2190101F1020, 2190102F1025, 2190103F1020, 2190104F1024
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1005137, 1005138, 1021103, 1021104, 1021105, 1021106, 1021107, 1021108, 1021109, 1021110, 1021111, 1021112, 1021113, 1021114, 1021115, 1021116, 1021117, 1021118, 1021119, 1021120, 1021121, 1021122, 1021123, 1021124, 1021125, 1021126
Country: MT	Medicines Authority	Identifier(s): MA1396/00201, MA1396/00202
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 204M2004
Country: NG	Registered Drug Product Database	Identifier(s): 04-8468
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67262001, W67263001
Country: SG	Health Sciences Authority	Identifier(s): 13055P, 13056P, 13057P, 13059P, 13060P, 13061P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 26323011, 26323012
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699532095633, 8699532095640, 8699532095671, 8699532095688
Country: US	FDA, National Drug Code	Identifier(s): 0069-2150, 0069-2160, 0069-2170, 0069-2180, 0069-2190, 0069-2250, 0069-2260, 0069-2270
Country: ZA	Health Products Regulatory Authority	Identifier(s): A39/7.0/0326, A39/7.0/0327, A39/7.0/0328, A39/7.0/0329, A39/7.0/0330, A39/7.0/0331, A39/7.0/0332, A39/7.0/0333